ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00179751
Recruitment Status : Terminated
First Posted : September 16, 2005
Last Update Posted : November 7, 2005
Sponsor:
Collaborator:
Prologue Research International
Information provided by:
Celgene

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : August 2006